comparemela.com

துறை ஆஃப் கண் மருத்துவம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Santen and Sydnexis execute an exclusive licensing agreement for SYD-101, a novel investigational treatment for progressive childhood myopia

Santen SA, a specialist in ophthalmology, and Sydnexis Inc., a biopharmaceutical company focused on the development of therapies for the treatment of progressive myopia, announce the signing of an exclusive licensing agreement for SYD-101, Sydnexis’ investigational proprietary low dose atropine formulation, for .

Renowned Eye Surgeon Named Vice Chair for Ophthalmology Education & Director of Cornea Service at NYU Langone Health

Renowned Eye Surgeon Named Vice Chair for Ophthalmology Education & Director of Cornea Service at NYU Langone Health
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.